Harding, J. J., Fan, J., Oh, D., Choi, H. J., Kim, J. W., Chang, H., Bao, L., Sun, H., Macarulla, T., Xie, F., Metges, J., Ying, J., Bridgewater, J., Wasan, H. S., Ducreux, M. P., Bao, Z., Garfin, P. M., Fuller, D. S., Jayia, P., Pant, S. (2026). Landmark analysis of overall survival (OS) by objective response in patients (pts) with previously treated, advanced HER2-positive biliary tract cancer (BTC): Post hoc analysis of the HERIZON-BTC-01 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.545